Ann: AGM Chairman address and CEO presentation, page-19

i was NOT very happy with references to Gillead, and remdesivir, a bit issue with that treatment - only approved via polictical corrupt means.. against many concerns and lots of reports/studies that it does NOT work.....but it is a case that with SPL ...it has made it more effective.? Does anyone know?

as more info about Gillead and remedivir come out, our share price will drop, how will our uninformed marketing team get out of this one, in backing Gillead....hope I'm wrong, as i'm still holding shares in hope its other pipelines and agreement come online,, and $4 is a good look and undervalued in about 1 years or less